Prescription drug · ANDA
doxepin NDC 70771-1529
Doxepin hydrochloride 6 mg/1 · Tablet · Oral · Zydus Lifesciences Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70771-1529-0 | 70771152900 | 1000 TABLET in 1 BOTTLE (70771-1529-0)Marketed from Jun 30, 2024 | |
| 70771-1529-1 | 70771152901 | 100 TABLET in 1 BOTTLE (70771-1529-1)Marketed from Jun 30, 2024 | |
| 70771-1529-3 | 70771152903 | 30 TABLET in 1 BOTTLE (70771-1529-3)Marketed from Jun 30, 2024 | |
| 70771-1529-4 | 70771152904 | 10 BLISTER PACK in 1 CARTON (70771-1529-4) / 10 TABLET in 1 BLISTER PACKMarketed from Jun 30, 2024 | |
| 70771-1529-5 | 70771152905 | 500 TABLET in 1 BOTTLE (70771-1529-5)Marketed from Jun 30, 2024 | |
| 70771-1529-9 | 70771152909 | 90 TABLET in 1 BOTTLE (70771-1529-9)Marketed from Jun 30, 2024 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- doxepin
- Generic name (nonproprietary)
- doxepin
- Active ingredients
- Doxepin hydrochloride — 6 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Zydus Lifesciences Limited
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 202761
- Marketing start
- Listing expires
- Identifiers
- Product ID 70771-1529_2a2843b4-5867-4df6-af9a-dbe0264d6f1bSPL ID 2a2843b4-5867-4df6-af9a-dbe0264d6f1bSPL set ID 1461ede6-24f0-42a1-b801-0cf4ef404985RxCUI 966787, 966793UNII 3U9A0FE9N5UPC 0372578182069, 0372578181062
- Pharmacologic class
- Tricyclic Antidepressant
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N470771152900followed by a unit qualifier and the quantityPackage 70771-1529-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Other NDCs under ANDA 202761
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| doxepin | Doxepin hydrochloride 3 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1528 |
| doxepin | Doxepin hydrochloride 3 mg/1 | TabletOral | Viona Pharmaceuticals Inc | 72578-181 |
| doxepin | Doxepin hydrochloride 6 mg/1 | TabletOral | Viona Pharmaceuticals Inc | 72578-182 |